Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Fluorescence Immunoassay Based on Nitrogen Doped Carbon Dots for the Detection of Human Nuclear Matrix Protein Nmp22 As Biomarker for Early Stage Diagnosis of Bladder Cancer Publisher



Othman HO1, 2 ; Salehnia F2 ; Hosseini M3 ; Hassan R1 ; Faizullah A1 ; Ganjali MR2, 4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Chemistry Department, College of Science, Salahaddin University–Erbil, Iraq
  2. 2. Center of Excellence in Electrochemistry, Faculty of Chemistry, University of Tehran, Tehran, 1417614418, Iran
  3. 3. Department of Life Science Engineering, Faculty of New Sciences & Technologies, University of Tehran, Tehran, 1417614418, Iran
  4. 4. Biosensor Research Center, Endocrinology and Metabolism Molecular–Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, 1417614418, Iran

Source: Microchemical Journal Published:2020


Abstract

A selective, fast acting and eco–friendly fluorescence immunoassay technique based on Nitrogen doped carbon dots (NCDs) is proposed for the detection of Nuclear Matrix Protein 22 (NMP22, antigen). Via the hydrothermal method and with the use of citric acid and urea, we synthesized NCDs with high quantum yield. Monoclonal antibodies (mAb, antibody) were labeled with NCDs through the EDC[sbnd]–NHS amidization technique and, in order to carry out the immunoreaction between the antigen and antibody, the resulting NCDs –mAb conjugates were then incubated with a small amount of NMP22). The established immunocomplex on the carboxylated NCDs led to the quenching of the fluorescence intensity. Under optimal conditions, a linear correlation between the change in fluorescence intensity and NMP22 concentration in the range of 1.3–16.3 ng/mL was observed and a detection limit of 0.047 ng/mL (47 pg/mL) was attained. This detection method was successfully able to determine NMP22 in human urine samples, with recoveries ranging from 96.50% to 103.61%. These results provide ample proof regarding the potential use of NCDs as fluorescence labels in immunoassays. © 2020 Elsevier B.V.